Castle Biosciences earnings were -$5.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CSTL earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$25.8M, down 369.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CSTL reported annual earnings of $18.2M, with -131.7% growth. The next CSTL earnings date is Aug 11, 2025.
What were Castle Biosciences's earnings last quarter?
On CSTL's earnings call on Invalid Date, Castle Biosciences (NASDAQ: CSTL) reported Q1 2025 earnings per share (EPS) of -$0.90, up 900% year over year. Total CSTL earnings for the quarter were -$25.85 million. In the same quarter last year, Castle Biosciences's earnings per share (EPS) was -$0.09.
The next CSTL earnings call is Invalid Date. Add CSTL to your watchlist to be reminded of Castle Biosciences's next earnings date.
Is Castle Biosciences profitable or losing money?
As of the last Castle Biosciences earnings report, Castle Biosciences is currently losing money. Castle Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$5.07 million, a 83.54% decrease year over year.
What was CSTL's earnings growth in the past year?
As of Castle Biosciences's earnings date in Invalid Date, Castle Biosciences's earnings has grown year over year. CSTL earnings in the past year totalled -$5.07 million.
What are Castle Biosciences's earnings expectations?
The current EPS estimate for Castle Biosciences's earnings report in Invalid Date is -$0.51.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.